Biotechnology Analyst Schimmer discusses the new coverage roll-out, Top Picks BBIO, MIRM, RCKT, CABA, LBPH, favorite biotech investment themes and navigating a bearish biotech tape on an Analyst/Industry conference call to be held on October 24 at 10 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BBIO:
- BridgeBio initiated with an Overweight at Cantor Fitzgerald
- BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BridgeBio reports inducement grants under Nasdaq listing rule
- BridgeBio Pharma Announces New England Journal of Medicine Publication of Positive Encaleret Proof-of-Concept Phase 2b Results in Patients with Autosomal Dominant Hypocalcemia Type 1 (ADH1)
- BridgeBio announces proof-of-concept Phase 2b data on encaleret
